Genedrive (LON:GDR)‘s stock had its “buy” rating restated by investment analysts at Peel Hunt in a report released on Wednesday.
Shares of Genedrive opened at GBX 30.50 ($0.39) on Wednesday, Marketbeat reports. Genedrive has a one year low of GBX 25 ($0.32) and a one year high of GBX 44.50 ($0.58).
Genedrive Company Profile
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. It operates through three divisions: Preclinical Research Services, Pharmacogenomic Services, and Diagnostics.
Recommended Story: Market Capitalization – What it Means for Investors
Receive News & Ratings for Genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genedrive and related companies with MarketBeat.com's FREE daily email newsletter.